Pricing & Access· May 22, 2026 · 12 min read
ASP lag after launch: why buy-and-bill economics can break in the first quarters
By Ran Chen#Medicare Part B#ASP#Buy and Bill
Topic
ASP
Average Sales Price methodology, quarterly ASP pricing files, WAC-based reimbursement, and Part B drug payment limits.
Pricing & Access· May 22, 2026 · 9 min read
J-code timing and interim billing risk for new buy-and-bill biologics
By Ran Chen#Medicare Part B#HCPCS#J-Code